Advertisement

Journal of Endocrinological Investigation

, Volume 11, Issue 2, pp 103–106 | Cite as

The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man

  • D. Esposti
  • P. Lissoni
  • R. Mauri
  • F. Rovelli
  • L. Orsenigo
  • S. Pescia
  • G. Vegetti
  • G. Esposti
  • F. Fraschini
Article

Abstract

Several observations have demonstrated that the opioid system can modulate melatonin secretion from the pineal gland and that the effects of opioids may require a pineal participation. In contrast, the role played by the pineal gland in regulating the synthesis and secretion of endorphins and enkephalins in still obscure. To establish whether the neuroendocrine activity of melatonin are mediated by endogenous opioids and to demonstrate a possible action exerted by the pineal gland on opioid peptides, GH and LH serum mean levels were evaluated by RIA in 12 healthy subjects of both sexes after melatonin injection alone (0.4 mg/kg bw im at 09:00 h) and on a separate occasion after a simultaneous administration of melatonin and naloxone (1.2 mg iv as a bolus, followed by an iv infusion of 1.6 mg/h for 3 h). On an other occasion, the study was performed during saline or naloxone infusion alone. In each test, venous blood samples were collected at −20, 0, 30, 60, 90, 120 and 180 min. A significant rise of GH was observed after melatonin injection alone. The simultaneous infusion of naloxone blocked melatonin-induced GH rise. Melatonin did not affected LH serum levels, while it was able to reduce LH increase induced by naloxone. These preliminary results suggest that some neuroendocrine effects of melatonin might be mediated by a modulation on the opioid tone.

Key-words

Melatonin pineal gland naloxone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Esposti D., Esposti G., Fraschini F. Effect of morphine on plasma melatonin in the rat. III Colloquium of the European Pineal Study Group. Pécs, Hungary, August 13–17, 1984.Google Scholar
  2. 2.
    Zatz M., Brownstein M.J. Central depressant rapidly reduce nocturnal serotonin-N-acetyltransferase activity in the rat pineal gland. Brain. Res. 160: 381, 1979.PubMedCrossRefGoogle Scholar
  3. 3.
    Claustrat B., Chazot G., Brun J. Melatonin secretion in man: stimulating effect of destryrosine gamma endorphin. Neuroendocrinol. Lett. 3: 35, 1981.Google Scholar
  4. 4.
    Geffard M., Gaffori O., Chaveau J., Muyard J.P., Le Moal M. Dramatic increase in pineal gland melatonin levels in the rat after subcutaneous injection of des-tyrosine gamma-endorphin. Neurosci. Lett. 27: 329, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Gaffori O., Geffard M., Van Ree J.M. Des-Tyr-γ-Endorphin and haloperidol increase pineal gland melatonin levels in rats. Peptides 4: 393, 1983.PubMedCrossRefGoogle Scholar
  6. 6.
    Lissoni P., Esposti D., Esposti G., Mauri R., Resentini M., Morabito F., Delitala G., Fumagalli P., Santagostino A., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. J. Neural. Transm. 65: 63, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Lissoni P., Mauri R., Resentini M., Morabito F., Djemal S., Fraschini F. The effect of naloxone on serum melatonin level. First International Meeting of the Italian Society of Endocrinology. Recent Progress in Opioid Research, p. 39, Viareggio, Italy, October 6–8, 1983.Google Scholar
  8. 8.
    Lowenstein P.R., Pereyra E.N., Solveyra C.G., Cardinali D.P. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. Eur. J. Pharmacol. 98: 261, 1984.PubMedCrossRefGoogle Scholar
  9. 9.
    Lakin M.L., Miller C.H., Stott M.L., Winters W.D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci., 29: 2543, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Lissoni P., Mauri R., Resentini M., Morabito F., Fraschini F., Fumagalli P., Santagostino A. Beta-endorphin levels after melatonin administration in man. J. Steroid Biochem. 20: 1458, 1984.Google Scholar
  11. 11.
    Kumar M.S.A., Chen C.L., Sharp D.C., Liu J.M., Kalra P.S., Kalra S.P. Diurnal fluctuations in methionine-enkephalin levels in the hypotalamus and preoptic area of the male rat: effects of pinealectomy. Neuroendocrinology 35: 28, 1982.PubMedCrossRefGoogle Scholar
  12. 12.
    Anton-Tay F., Chou C., Anton S., Wurtman R.J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 162: 277, 1968.PubMedCrossRefGoogle Scholar
  13. 13.
    Anton-Tay F., Diaz J.L., Fernandez-Guardiola A. On the effect of melatonin upon brain. Its possible therapeutic implications. Life Sci. 10: 841, 1971.CrossRefGoogle Scholar
  14. 14.
    Zisapel N., Laudon M. Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro: inhibition by melatonin. Biochem. Biophys. Res. Comm. 104: 1610, 1982.PubMedCrossRefGoogle Scholar
  15. 15.
    Morley J.E., Baranetsky N.G., Wingert T.D., Carlson H.E., Hershman J.M., Melmed S., Levin S.R., Jamison K.R., Weitzman R., Chang R.J., Varner A.A. Endocrine effects of naloxone-induced opiate receptor blockade. J. Clin. Endocrinol. Metab. 50: 251, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Quigley M.E., Yen S.S.C. The role of endogenous opiates on LH secretion during the menstrual cycle. J. Clin. Endocrinol. Metab. 51: 179, 1980.PubMedCrossRefGoogle Scholar
  17. 17.
    Delitala G., Devilla L., Russo N.R. On the role of dopamine receptors in the naloxone-induced hormonal changes in man. J. Clin. Endocrinol. Metab. 56: 181, 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Smythe G.A., Lazarus L. Growth hormone responses to melatonin in man. Science 184: 1373, 1975.CrossRefGoogle Scholar
  19. 19.
    Weinberg U., Weitzman E.D., Fukushima D.K., Cnacel G.F., Rosenfeld R.F. Melatonin does not suppress the pituitary luteinizing hormone response to luteinizing hormone-releasing in men. J. Clin. Edocrinol. Metab. 51: 161, 1980.CrossRefGoogle Scholar
  20. 20.
    Nordlund J., Lerner A.B. The effects of oral melatonin on skin color and on the release of pituitary hormones. J. Clin. Endocrinol. Metab. 45: 768, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    Smythe G.A., Lazarus L. Suppression of human growth hormone secretion by melatonin and cyproheptadine. J. Clin. Invest. 54: 116, 1974.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Stubbs W.A., Delitala G., Jones A., Jeffcoate W.J., Edwards C.R.W., Ratter S.J., Besser G.M., Bloom S.R., Al-berti K.G.M.M. Endocrine and metabolic responses to an enkephalin analogue in normal man. Lancet 2: 1225, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1988

Authors and Affiliations

  • D. Esposti
    • 1
  • P. Lissoni
    • 2
  • R. Mauri
    • 2
  • F. Rovelli
    • 2
  • L. Orsenigo
    • 2
  • S. Pescia
    • 2
  • G. Vegetti
    • 2
  • G. Esposti
    • 3
  • F. Fraschini
    • 3
  1. 1.Istituto di Fisiologia Umana II, Facoltà di MedicinaItaly
  2. 2.Ospedale S. GerardoMonza
  3. 3.Cattedra di Chemioterapia, Facoltà di MedicinaItaly

Personalised recommendations